50-198-0650
IBDV Rabbit anti-Virus, Polyclonal, Bioss
Manufacturer: Bioss
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-198-0650-Each-of-1 | In Stock | ₹ 36,897.75 |
50-198-0650 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 36,897.75
GST (18%): ₹ 6,641.595
Total Price: ₹ 43,539.345
Antigen
IBDV
Classification
Polyclonal
Conjugate
Unconjugated
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Applications
Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration
1 μg/mL
Formulation
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen
Derived from IBDV vaccine strain B87 .
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
-20°C
Form
Liquid
Related Products
Description
- Infectious bursal disease (IBD) is caused by infectious bursal disease virus (IBDV) an avian Birnavirus first described in the USA near the town of Gumboro Delaware and thus the disease is also known as Gumboro disease
- There are 3 recognized pathogenic types of IBDV; classic virulent (cvIBDV), sub-clinical (scIBDV), and very virulent (vvIBDV)
- All three pathogenic types of IBDV cause immune suppression which leads to secondary infections and a failure to produce an immune response to vaccines
- The cvIBDV typically cause a high morbidity and low mortality disease while the scIBDV cause very little morbidity and no mortality
- The vvIBDV cause an acute disease in chickens characterized by high morbidity and high mortality.
Compare Similar Items
Show Difference
Antigen: IBDV
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: Derived from IBDV vaccine strain B87 .
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
IBDV
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin)
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
Derived from IBDV vaccine strain B87 .
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: EPHA10
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: ELISA, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human EPHA10.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
EPHA10
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
ELISA, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human EPHA10.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: KNDC1
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Human
Product Type: Antibody
Isotype: IgG
Applications: ELISA, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from human KNDC1.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
KNDC1
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Human
Product Type:
Antibody
Isotype:
IgG
Applications:
ELISA, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from human KNDC1.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid
Antigen: Capsid Protein
Classification: Polyclonal
Conjugate: Unconjugated
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Virus
Product Type: Antibody
Isotype: IgG
Applications: Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 μg/mL
Formulation: PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen: KLH conjugated synthetic peptide derived from PCV2 capsid protein.
Quantity: 100 μL
Primary or Secondary: Primary
Content And Storage: -20°C
Form: Liquid
Antigen:
Capsid Protein
Classification:
Polyclonal
Conjugate:
Unconjugated
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Virus
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 μg/mL
Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH
Immunogen:
KLH conjugated synthetic peptide derived from PCV2 capsid protein.
Quantity:
100 μL
Primary or Secondary:
Primary
Content And Storage:
-20°C
Form:
Liquid